Navigation Links
Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
Date:11/5/2007

COLUMBIA, Md., Nov. 5 /PRNewswire-FirstCall/ -- Already a leader in the DHA omega-3 food and supplements industries, Martek Biosciences Corporation announced today that it will be expanding its reach in the animal feed market with a worldwide exclusive distributorship agreement for its DHA Gold(R) product with Novus International, Inc. Martek will serve as Novus's exclusive worldwide DHA supplier for all of its poultry and swine feed and enrichment products. All Novus products containing DHA Gold(R) will display the DHA Gold(R) trademark.

"This partnership with Novus represents a new opportunity for Martek," said Joe Buron, vice president of sales and marketing for Martek. "Animal feed and nutrition represent a logical extension of Martek's core technology and we are pleased to be working with an industry leader and innovator like Novus as we expand into this market."

DHA Gold(R) biomass animal feed ingredient is a dried, whole-cell algae product used to provide DHA enrichment for commercially raised animals. Adding DHA Gold(R) to animal feed is a safe and effective way to enrich foods such as meat, eggs and milk. DHA Gold(R) is unique in the market because it is from a sustainable and vegetarian source, has a more stable and consistent composition than fish oil and fish byproducts, and is free of ocean-borne contaminants.

Novus International, Inc. is headquartered in St. Louis, Missouri, U.S.A. and serves customers in more than 80 countries around the world. An industry leader in animal nutrition and health, Novus products include ALIMET(R) and MHA(R) feed supplements, ACTIVATE(R) nutritional feed acid, ACIDOMIX(TM) preservative premixture, ADVENT(R) coccidiosis control, MINTREX(R) organic trace minerals, SANTOQUIN(R) feed preservative and many other specialty ingredients. Arenus (http://www.arenusperformance.com), part of Novus International, Inc., focuses on developing performance products for the equine, canine, and human markets. Novus is privately owned by Mitsui and Co., Ltd. and Nippon Soda Co., Ltd. For more information visit http://www.novusint.com.

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM) (http://www.lifesdha.com), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements, and DHAGold(R), a sustainable and vegetarian source of DHA for animal feed. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

Contact:

Cassie France-Kelly

Public Relations

(443) 542-2116

media@martek.com

Kyle Stults

Investor Relations

(410) 740-0081

investors@martek.com


'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Martek Announces Third Quarter 2007 Financial Results
3. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
4. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
5. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
6. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
7. Pot bellies linked to early signs of cardiovascular disease
8. MSU engineering team designs innovative medical device
9. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
10. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
11. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... Watch the video ... Month, representatives from Organic Consumers Association, National Health Freedom Action, March Against Monsanto, ... Voice for Choice, Moms Across America, Freedom and Ethics Alliance and the Vaccine ...
(Date:3/29/2017)... ... 2017 , ... During the last week of March, Chad Kawa, MD of ... in the local community. , Colon cancer is the second leading cause of ... while it is small, confined and easier to treat. If you are 50 or ...
(Date:3/29/2017)... ... March 30, 2017 , ... Grass pollen is the main cause of hay fever in ... The season for grass pollen runs from May to July each year; with the worst ... to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy Network, a ... at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. , Ben ... the visionary leader in the training of physicians, scientists, and members of the ...
(Date:3/29/2017)... ... ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, is now ... without a referral. Dr. Cotey knows that interceptive orthodontics in Mt. Horeb, ... receive early treatment, they may achieve straight teeth with less treatment in their teenage ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Zynex (OTCQB: ZYXI), an innovative ... of non-invasive medical devices for pain management, stroke rehabilitation, ... will host the Company,s 2016 full-year investor webcast on Monday, ... The Company expects to file its 2016 ... ...
(Date:3/29/2017)... , March 29, 2017 According to a new ... Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, ... 2021" published by MarketsandMarkets, the market is expected to reach USD 1,215.4 ... of 6.5% from 2016 to 2021. Continue ... ...
(Date:3/29/2017)... WASHINGTON , March 29, 2017  The Pharmaceutical ... regarding a new PhRMA report on patient out-of-pocket spending: ... for Medicare and Medicaid Services (CMS), the average amount ... be 13% of drug spending in 2016, down from ... is a pricing problem, not a coverage problem. Health ...
Breaking Medicine Technology: